Biotech Stock Soars on Regulatory Breakthrough
Published on 10/04/2025 at 09:27 | Redaktion boerse-global.de
Shares of Applied Therapeutics continued their remarkable ascent on Friday, climbing 7.04% to close at $1.00. This performance caps an extraordinary two-week surge exceeding 130%, driven by market optimism surrounding reported progress in discussions with the U.S. Food and Drug Administration.
The catalyst for this dramatic upward move originated in late September. Market sentiment shifted significantly following indications that Applied Therapeutics and the FDA may have reached an understanding regarding a confirmatory study for a drug targeting a rare disease. This development propelled the biotech firm’s valuation substantially higher in a very short period.
This potential regulatory alignment could mark a pivotal moment for the company. The news arrives just months after Applied Therapeutics faced a notable setback in August,... Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
